BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines BRUKINSA — Global Revenue Growth YoY by Quarter
BRUKINSA — Global Revenue Growth YoY (%) (%)
BeOne Medicines BRUKINSA — Global Revenue Growth YoY: 31.4% in Q2 2026, down 17.6 pts from a year earlier. That is the lowest of the 17 quarters on record here.
Where the Q2 2026 figure comes from
“Global sales of BRUKINSA totaled $1,247.6 million in the second quarter, representing a 31.4% increase”
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K MD&A & Form 8-K Earnings Releases.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | BRUKINSA — Global Revenue Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 31.4% | -17.6 pts | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 38.3% | -23.8 pts | Form 10-Q (filed 2026-05-06) ↗ |
| Q3 2025 | Sep 30, 2025 | 50.8% | -42.2 pts | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 49.0% | -57.8 pts | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 62.1% | -69.0 pts | Form 10-Q (filed 2025-05-07) ↗ |
| Q3 2024 | Sep 30, 2024 | 93.0% | -37.0 pts | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 106.8% | -32.6 pts | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 131.1% | +28.5 pts | Form 10-Q (filed 2024-05-08) ↗ |
| Q3 2023 | Sep 30, 2023 | 130.0% | -6.2 pts | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 139.4% | -64.1 pts | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 102.6% | -269.4 pts | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 101.0% | -277.0 pts | Form 8-K (filed 2023-02-27) ↗ |
| Q3 2022 | Sep 30, 2022 | 136.2% | -183.8 pts | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 203.5% | – | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 372.0% | – | Form 10-Q (filed 2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | 378.0% | – | Form 8-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 320.0% | – | Form 10-Q (filed 2021-11-04) ↗ |
Cite this data
StockData. (2026). BeOne Medicines BRUKINSA — Global Revenue Growth YoY (%), quarterly Q3 2021–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/prod-brukinsa-ww-yoy
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.